Medical management is increasingly used to improve walking in people with MS, but more and better studies are needed, particularly of pharmacotherapy combined with walking therapies.
Cannabis Extract Improves Spasticity Without Increasing Weakness in Patients With MS
A pooled analysis of three randomized trials of nabiximols helps lay the groundwork for an FDA submission in 2021. Approval would yield the first novel treatment for spasticity in multiple sclerosis in many years.